---
title: Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic
  markers of both severity and outcome
date: '2021-12-20'
linkTitle: http://link.springer.com/10.1007/s11306-021-01859-3
source: Latest Results for Metabolomics
description: ' <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section
  id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">The
  diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic
  acid sequences. Properties of the host response are not measured but are key in
  determining outcome. Although metabolic profiles are well suited to capture host
  state, most metabolomics studies are either underpowered, measure only a restricted
  subset of metabolites, compare infected individuals against uninfected control cohorts
  that are not ...'
---
 <h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Introduction</h3> <p class="a-plus-plus">The diagnosis of COVID-19 is normally based on the qualitative detection of viral nucleic acid sequences. Properties of the host response are not measured but are key in determining outcome. Although metabolic profiles are well suited to capture host state, most metabolomics studies are either underpowered, measure only a restricted subset of metabolites, compare infected individuals against uninfected control cohorts that are not ...